Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2020-06-29 2020-06-08
Drug Identification Number 02303418 02303418
Brand name SANDOZ METOPROLOL SR SANDOZ METOPROLOL SR
Common or Proper name SANDOZ METOPROLOL SR SANDOZ METOPROLOL SR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients METOPROLOL TARTRATE METOPROLOL TARTRATE
Strength(s) 200MG 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 PRT BO 100 PRT BO
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-22 2020-05-22
Estimated end date 2020-08-07 2020-07-10
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments